Like other bispecific antibodies (Bi-Abs) that validated for treating various diseases 49, 50, activated T cell (ATC) armed with the anti-CD3 x anti-B7-H3 (B7-H3Bi-Ab), had specific cytotoxic activity against tumor cells by ADCC. Here, CD276 is linked to neoplasm.